Ionis Pharmaceuticals, Inc. Inventory
Ionis Pharmaceuticals, Inc. (IONS) had Inventory of $50.83 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-07-29
- 2026-06-30: Inventory, Net $50.83M.
- 2026-03-31: Inventory, Net $5.56M.
- 2025-12-31: Inventory, Net $10.05M.
- 2025-09-30: Inventory, Net $10.47M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $50.83M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $5.56M 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $10.05M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $10.47M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $8.48M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $11.50M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $12.51M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $28.45M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $28.72M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $30.26M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $7.44M 10-K · filed 2025-02-19 | $28.43M 10-K · filed 2024-02-21 |
| 2023-09-30 | $25.63M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $25.54M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $22.20M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $22.03M 10-K · filed 2024-02-21 | |
| 2022-09-30 | $20.64M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $19.81M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $24.03M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $24.81M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $22.93M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $24.10M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $22.20M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $21.96M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $22.17M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $23.72M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $22.89M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $18.18M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $19.38M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $18.50M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $11.06M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $8.58M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $8.38M 10-Q · filed 2018-11-06 | |
| 2017-12-31 | $9.98M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |